BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

May 08, 2017

|

NEW YORK (GenomeWeb) – Becton Dickinson today said it has commenced registered offerings of $2.25 billion of common stock and $2.25 billion of depositary shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

BD Commences Offerings of $4.5B of Common Stock, Depositary Shares

To read the full story....

Breaking News

BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

Wyss Institute Licenses Multiplex Biosensing Platform to iQ Group Global for COVID-19 Test

BTIG Initiates Coverage of Oncocyte With Buy Rating

Canary Health, Divoc Laboratories Partner on Clinical Trial for COVID-19 Rapid Breath Test

Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test

BARDA Awards $13M to Siemens for Development of SARS-CoV-2 High Throughput Antigen, Antibody Assays

What's Popular?

Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing Program

Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test

Sponsorships